Loading organizations...
Daishin Private Equity operates as the dedicated private equity arm of Daishin Financial Group, specializing in managing private equity funds for institutional investors. The firm employs a multifaceted investment approach, primarily focusing on growth capital, mezzanine financing, co-investments, and secondary strategies. Its capabilities include sourcing and executing complex transactions, leveraging deep industry insights to identify promising opportunities across various sectors.
The entity launched on April 17, 2014, as a strategic expansion within the established Daishin Financial Group, which was founded in 1962. This move allowed the broader financial conglomerate to extend its reach into alternative asset classes, capitalizing on its long-standing financial expertise and market presence to build out a dedicated private equity platform.
Daishin Private Equity primarily serves large institutional investors, including significant entities such as the National Pension Service and the Korea Development Bank. The firm’s vision is centered on continuously broadening its investment scope, deploying capital with highly skilled financial experts, and fostering growth through innovative strategies that align with its clients' long-term objectives.
Daishin Private Equity has 3 tracked investments across 3 companies. The latest tracked deal is $10.9M Series B in Logpresso in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 16, 2025 | Logpresso | $10.9M Series B | — | CJ Investment, K2 Investment Partners, Junseok LEE, SBI Investment Korea, Sopoong Ventures |
| Jun 19, 2025 | Colosseum | $19.5M Series B | — | Anda Asia Ventures, A Stone Ventures, CJ Investment, Hyosung Ventures, Industrial Bank OF Korea, Muirwoods Ventures |
| Oct 1, 2020 | ILIAS Biologics | $20.6M Series B | — | Asset ONE, Daedeok Venture Partners, DEV Sisters Ventures, Genie Asset Management, Hanyang Securities/yeolim Partners, HB Investment, Kiwoom Securities, Meritz Securities, Timefolio Asset Management |